Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04488393 · ClinicalTrials.gov registry record
Clinical Performance of NIPT in Multiple Gestation Pregnancies
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT04488393: Completed study, sponsored by University of Pennsylvania.
NCT04488393 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04488393 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
This study plans to evaluate the clinical performance of the MaterniT21 PLUS and/or GENOME Laboratory Developed Test, in the detection of fetal trisomy 21 in circulating cell-free DNA extracted from maternal blood samples obtained from women pregnant with a twin gestation.
Interventions
- DEVICE MaterniT21 PLUS and GENOME Laboratory-Developed Tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2022-06-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04488393
The ClinicalTrials.gov registry entry for NCT04488393 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MaterniT21 PLUS and GENOME Laboratory-Developed Tests is the first listed.
NCT04488393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04488393 about?
NCT04488393 is a clinical study titled "Clinical Performance of NIPT in Multiple Gestation Pregnancies". This study plans to evaluate the clinical performance of the MaterniT21 PLUS and/or GENOME Laboratory Developed Test, in the detection of fetal trisomy 21 in circulating cell-free DNA extracted from maternal blood samples obtained from women pregnant with a twin gestation.
What is the current status of trial NCT04488393?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2020-03-01. Estimated completion is 2022-06-19.
What interventions are being tested in trial NCT04488393?
The interventions under investigation include: MaterniT21 PLUS and GENOME Laboratory-Developed Tests (DEVICE).
Who is sponsoring clinical trial NCT04488393?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.